EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer

Mubassir Khan, Razi Ullah iD, Syed Mubassir Shah, Umar Farooq, Jun Li

ACS Applied Bio Materials · 19.05.2025 · 8 (5) · 3571-3600

DOI: 10.1021/acsabm.5c00040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, online erschienen am 28.04.2025. Verfasst von Mubassir Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, P.…. Hauptthemen laut MEDLINE: Breast Neoplasms, Manganese, Antineoplastic Agents, Biocompatible Materials. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 275 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is one of the most common cancers among women and is associated with high mortality. Traditional modalities, including surgery, radiotherapy, and chemotherapy, have achieved certain advancements but continue to combat challenges including harm to healthy tissues, resistance to treatment, and adverse drug reactions. The rapid advancements in nanotechnology recently facilitated the exploration of innovative strategies for breast cancer therapy. Manganese-based nanotherapeutics have attracted great attention because of their unique characteristics such as tunable structures/morphologies, versatility, magnetic/optical properties, strong catalytic activities, excellent biodegradability, and biocompatibility. In this review, we highlighted different types of Mn-based nanotherapeutics to modulate TME, including metal-immunotherapy, alleviating tumor hypoxia, and increasing reactive oxygen species production, and we emphasized its role in magnetic resonance imaging (MRI)-guided therapy, photoacoustic imaging, and theranostic-based therapy along with a therapeutic carrier, all of which were discussed in the context of breast cancer. Hopefully, the present review will provide insights into the current landscape and future directions of multifunctional applications of Mn-based nanotherapeutics in the field of breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsManganeseAntineoplastic AgentsBiocompatible MaterialsHumansFemaleAnimalsMaterials Testing

Stichwörter der Autor:innen

Breast cancermanganesenanoparticlesreactive oxygen speciestumor hypoxiatumor microenvironment

Substanzen

ManganeseAntineoplastic AgentsBiocompatible Materials

Autor:innen und Institutionen

  • Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, P.R. China.
  • Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Lab for Vascular Implants, College of Bioengineering, Chongqing University, Chongqing 400030, China.
  • Jinfeng Laboratory, No. 313 Jinyue Road, High-tech Zone, Chongqing 401329, China.
  • Department of Biotechnology, Abdul Wali Khan University, KPK, Mardan 23200, Pakistan.

ORCID-Profile: Razi Ullah

Zitieren

APA

Khan, M., Ullah, R., Shah, S. M., Farooq, U., & Li, J. (2025). Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer. ACS Applied Bio Materials, 8(5), 3571-3600. https://doi.org/10.1021/acsabm.5c00040

Vancouver

Khan M, Ullah R, Shah SM, Farooq U, Li J. Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer. ACS Applied Bio Materials. 2025;8(5):3571-3600. doi:10.1021/acsabm.5c00040

BibTeX
@article{Khan2025,
  author = {Khan, Mubassir and Ullah, Razi and Shah, Syed Mubassir and Farooq, Umar and Li, Jun},
  title = {Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  volume = {8},
  number = {5},
  pages = {3571--3600},
  doi = {10.1021/acsabm.5c00040}
}
Kostenlos starten →